TrialClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2022

Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).

Alexandre Duvignaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.